bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced continued sales growth of its ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (BIAF) (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today ...
"The increase in CyPath Lung test volume demonstrates that physicians are increasingly recognizing the clinical value of CyPath Lung in detecting lung cancer at its earliest and most treatable stages, ...
bioAffinity Technologies, Inc. ( (BIAF)) just unveiled an announcement. On November 5, 2025, bioAffinity Technologies announced significant growth in the volume of their CyPath® Lung tests, with ...
Measuring lung function earlier in life would help identify people at risk of developing chronic obstructive pulmonary disease (COPD) and allow for more timely interventions, according to a new study ...
Widely used lung function tests often fail to detect lung disease in Black patients, according to research — and experts are calling for new methods of testing. Spirometry, the most common lung ...
Registry analysis suggests endoscopic lung volume reduction yields similar physiologic gains across sexes, but women report ...
Our lungs work tirelessly, providing the oxygen our bodies need to function properly, and also to maintain proper blood flow to our internal as well as external organs. Let's think, how often do we ...
One of the largest studies to investigate whether Preserved Ratio Impaired Spirometry (PRISm), an understudied low lung function state, is an early predictor of co-morbidities has found it is strongly ...
SAN ANTONIO, November 05, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases ...
October test volume 111% more than 2025 year-to-date monthly average SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (BIAF) (Nasdaq: BIAF; BIAFW), a biotechnology company advancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results